21
Participants
Start Date
January 31, 2005
Primary Completion Date
January 31, 2009
Study Completion Date
February 28, 2011
Rituximab
Rituximab will be given as a 375 mg/m\^2 intravenous infusion once weekly for four doses (days 1, 8, 15, and 22).
Mayo Clinic - Jacksonville, Jacksonville
Mayo Clinic Cancer Center, Rochester
Mayo Clinic Scottsdale, Scottsdale
Lead Sponsor
Collaborators (2)
Genentech, Inc.
INDUSTRY
Biogen
INDUSTRY
National Center for Research Resources (NCRR)
NIH
Mayo Clinic
OTHER